| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8595751 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 7 Pages |
Abstract
Idarucizumab improves safety in dabigatran-treated patients. Continued education about the availability and appropriate use of idarucizumab is necessary in Asia.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Li-Kai MD, PhD, Huey-Juan MD, MPH, Su-Kiat MD, PhD, Pen-Chih MD, Yuan-Po MD, Ping-Chen MD, Chun-Wei MD, Mao-Jen MD, PhD, Hsi-Ming MD, Jung-Tze MS, Yi-Heng MD, PhD,